The Alzheimer’s economy: is the new $56,000-a-year drug worth it?
Published
US approval of the Biogen treatment has given patients hope. But some experts worry expectations have been raised too high
Full ArticlePublished
US approval of the Biogen treatment has given patients hope. But some experts worry expectations have been raised too high
Full ArticleWhat universal healthcare should look like
The struggle to cover every American may continue for decades — and we need..
Watch VideoGovernment health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years,..